Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia
NCT ID: NCT05800782
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2023-10-15
2025-02-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia
NCT04799340
Memory Training in Patients With Amnestic Mild Cognitive Impairment
NCT01978353
Memory Training and Neural Plasticity
NCT05380739
Remediation of Spatial Neglect Trial
NCT01965951
Improvement of Memory in Mild Cognitive Impairment
NCT05708001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Memory Training
Participants will perform 6 weeks of face memory training (5 x 40 min sessions/week) that targets enhancing encoding to improve face recollection. As training progresses, the repetition lags (spaces between repeated foil faces) and number of faces will increase.
Face Memory Training
Computer-based training using faces targeting face memory
Perception Training
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on internal features (e.g., eyebrow-eye distance). As training progresses, the faces will become more challenging and the face sizes will vary.
Face Perception Training
Computer-based training using faces targeting improving face perception
Active Control Training
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on external facial features (e.g., hair). As training progresses, the faces will become more challenging and the face sizes will vary.
Placebo control training
Computer-based training using faces not targeting improving face perception or memory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Face Memory Training
Computer-based training using faces targeting face memory
Face Perception Training
Computer-based training using faces targeting improving face perception
Placebo control training
Computer-based training using faces not targeting improving face perception or memory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have lifelong histories of face recognition difficulties that impact everyday life (i.e., not associated with some event such as a stroke, seizure, etc)
* Score \> 2 standard deviations below the mean on the famous faces test and Cambridge Face Memory Test. This is in line with our previous studies and others in the literature.
Exclusion Criteria
* Participants with a history of mild TBI or simple concussion will not be excluded as long as it was \> 6 months ago and as long as they have not had repeated concussions (\>5).
* Participants will be excluded if they have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues.
* Additionally, participants will be excluded if they have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.
* Participants with a diagnosis of ADHD will be included as long as their medication has been consistent for the past 6 months.
* Participants who are currently dependent on alcohol or other substances will be excluded, as this may negatively impact cognitive performance.
* Participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention will be excluded.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston VA Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph DeGutis, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Harvard Medical School/VA Boston Healthcare Systems
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Boston Healthcare System
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.